These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 10642984)

  • 41. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoscopic evidence of calculus attachment to Randall's plaque.
    Matlaga BR; Williams JC; Kim SC; Kuo RL; Evan AP; Bledsoe SB; Coe FL; Worcester EM; Munch LC; Lingeman JE
    J Urol; 2006 May; 175(5):1720-4; discussion 1724. PubMed ID: 16600740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
    Aggarwal KP; Tandon S; Singh SK; Tandon C
    Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary oxalate and calcium excretion by dogs and cats diagnosed with calcium oxalate urolithiasis.
    Dijcker JC; Kummeling A; Hagen-Plantinga EA; Hendriks WH
    Vet Rec; 2012 Dec 22-29; 171(25):646. PubMed ID: 23180150
    [No Abstract]   [Full Text] [Related]  

  • 45. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
    Woelfel A; Kaplan RA; Pak CY
    Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New aspects in the treatment of oxalate lithiasis (author's transl)].
    Hautmann R; Hering FJ; Terhorst B; Lutzeyer W
    Urologe A; 1976 Jul; 15(4):148-52. PubMed ID: 960323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Calcium oxalate lithiasis. Relationship between biochemical risk factors and crystalline phase of the stone].
    Parent X; Boess G; Brignon P
    Prog Urol; 1999 Dec; 9(6):1051-6. PubMed ID: 10658250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals.
    Farell G; Huang E; Kim SY; Horstkorte R; Lieske JC
    J Am Soc Nephrol; 2004 Dec; 15(12):3052-62. PubMed ID: 15579508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual morphology of calcium oxalate calculi in primary hyperoxaluria.
    Daudon M; Estepa L; Lacour B; Jungers P
    J Nephrol; 1998; 11 Suppl 1():51-5. PubMed ID: 9604812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperoxaluria or hypercalciuria in nephrolithiasis: the importance of renal tubular functions.
    Lindsjö M; Fellström B; Danielson BG; Kasidas GP; Rose GA; Ljunghall S
    Eur J Clin Invest; 1990 Oct; 20(5):546-54. PubMed ID: 2124987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Physiopathology of idiopathic calcium lithiasis].
    Bataille P; Fournier A; el Esper N; Westeel PF
    Nephrologie; 1990; 11(1):29-42. PubMed ID: 2197570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium oxalate crystals in human pathology. Molecular analysis with the laser Raman microprobe.
    Pestaner JP; Mullick FG; Johnson FB; Centeno JA
    Arch Pathol Lab Med; 1996 Jun; 120(6):537-40. PubMed ID: 8651854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tamm-Horsfall glycoprotein and calcium nephrolithiasis.
    Hess B
    Miner Electrolyte Metab; 1994; 20(6):393-8. PubMed ID: 7783702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal stone formation. The inhibitory effect of urine on calcium oxalate precipitation.
    Rose MB
    Invest Urol; 1975 May; 12(6):428-33. PubMed ID: 1120635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Oxalate: its role in lithogenesis and composition of calcium oxalate lithiasis].
    Fernandez Rodríguez A; Arrabal Martín M; Domínguez Molinero JF; Mijan Ortiz JL; Sánchez Tamayo J; Zuluaga Gómez A
    Actas Urol Esp; 1995 Sep; 19(8):620-6. PubMed ID: 8669329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.